Skip to main content
. 2024 Jan 3;13(1):12403. doi: 10.1002/jev2.12403

TABLE 1.

Study population characteristics.

ME/CFS Controls p‐value
n 18 17 NA
Age (years) 44.4 ± 7.9 44.2 ± 13.4 0.87
BMI 27.8 ± 5.4 29.9 ± 5.8 0.26
Type of onset Sudden 83% NA NA
Gradual 17% NA NA
Bell Disability Scale Median (IQR) 30 (17.5) 100 (10) p < 0.0001
SF‐36 PCS Physical component summary 25.2 ± 6.7 56.2 ± 5.0 p < 0.0001
SF‐36 MCS Mental component summary 46.0 ± 8.1 54.5 ± 6.9 p = 0.0001
MFI total Multi‐dimensional fatigue inventory 84.4 ± 7.7 NA NA
CPET parameters (median (IQR)) VO2peak (mL/kg/min) 18.45 (3.775) 19.2 (3.4) 0.19
VO2@VT (mL/kg/min) 9.2 (2.6) 10.5 (2.6) 0.01
HRpeak (bpm) 156 (22.25) 161 (26) 0.59
RERpeak 1.25 (0.1375) 1.22 (0.11) 1
Work@peak (watts) 111.5 (25.75) 127 (26) 0.08
Time to peak (s) 454.5 (94.75) 529 (100) 0.02

Note: Shown are the mean and standard deviation for demographic parameters in ME/CFS patients and control subjects, except where otherwise indicated. For the Bell disability scale and SF‐36, a higher number corresponds to better health. For the MFI total score, a higher number corresponds to increased fatigue. VT, ventilatory threshold; HR, heart rate; RER, respiratory exchange ratio. The p‐values are from Wilcoxon rank sum tests comparing ME/CFS and control groups. NA, not applicable.